Skip to content

Fluid Responsiveness Tests in Critically Ill Patients During Admission to the Intensive Care Unit

Possibility of Applying Fluid Responsiveness Tests in Critically Ill Patients During Admission to the Intensive Care Unit - a Prospective Observational Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06729268
Enrollment
389
Registered
2024-12-11
Start date
2023-04-03
Completion date
2024-05-27
Last updated
2024-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Hypovolemia, Shock Circulatory

Brief summary

The goal of this observational study is to investigate the prevalence of conditions allowing the performance fluid responsiveness tests in critically ill patients during admission to the intensive care unit.

Detailed description

Patients admitted to the intensive care unit are very often hemodynamically unstable. In these cases fluid responsiveness tests should be performed to assess whether the patient would benefit from the fluid administration. However, fluid responsiveness tests have many limitations including lack of spontaneous breathing, necessity of invasive mechanical ventilation with tidal volume of \> 8 mL/kg ideal body weight, regular hearth rhythm, and lack of abdominal hypertension. In the study, the investigators evaluated the prevalence of conditions enabling the performance fluid responsiveness tests in patients admitted to the intensive care unit. An assessment was performed within the six hours after admission to the intensive care unit. Evaluation was based on transthoracic echocardiography, clinical examination of the patients, and data derived from anamnesis. The following fluid responsiveness tests were included into assessment: passive leg raising test, end-expiratory occlusion test, pulse pressure variation, stroke volume variation, velocity time integral variation in left ventricle output track, tidal volume challenge, inferior vena cava diameter variation, and superior vena cava diameter variation. The aim of the study was to assess how many patients have the conditions allowing performance fluid responsiveness tests during admission to the intensive care unit.

Interventions

None listed

Sponsors

Uniwersytecki Szpital Kliniczny w Opolu
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1\. Adult patients admitted to the intensive care unit

Exclusion criteria

1. Age under 18 2. The researcher unavailable in the intensive care unit 3. Patient assessment cannot be completed within the first six hours after admission to the ICU

Design outcomes

Primary

MeasureTime frameDescription
To assess the prevalence of conditions allowing the performance fluid responsiveness tests during admission to the intensive care unit.Six hours after admission to the intensive care unitThe primary aim of the study is to assess the prevalence of conditions allowing the performance fluid responsiveness tests during admission to the intensive care unit.

Secondary

MeasureTime frameDescription
To assess which fluid responsiveness test based on heart-lung interactions can be applied most often during admission to the intensive care unitSix hours after admission to the intensive care unitThe secondary aim of the study is to assess which fluid responsiveness test based on heart-lung interaction can be applied most often during admission to the intensive care unit
To assess the percentage of patients in shock whom fluid responsiveness tests can be performed during admission to the intensive care unitSix hours from the admission to the intensive care unit.Secondary aim include an assessment the percentage of patients in shock whom fluid responsiveness tests can be performed during admission to the intensive care unit.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026